AWH Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 May 2024 @ 16:00):

Aspira Women\'s Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States...

Stats
Today's Volume	30 977.00
Average Volume	28 461.00
Market Cap	26.77M
EPS	$0 ( 2024-05-15 )
Next earnings date	( $-0.320 ) 2024-08-12
Last Dividend	$0.260 ( 2016-12-16 )
Next Dividend	$0 ( N/A )
P/E	-1.520
ATR14	$0.0190 (0.88%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-13	Hombeck Torsten	Buy	22 000	EMPLOYEE STOCK OPTION (RIGHT TO BUY)
2024-05-13	Sandford Nicole	Buy	80 000	EMPLOYEE STOCK OPTION (RIGHT TO BUY)
2024-05-03	Milligan Sandra	Buy	30 000	EMPLOYEE STOCK OPTION (RIGHT TO BUY)
2024-04-01	Milligan Sandra	Buy	0
2024-02-15	Sandford Nicole	Buy	30 000	Employee stock option (right to buy)

INSIDER POWER
98.12
Last 89 transactions
Buy: 4 380 901 \| Sell: 195 424

Volume Correlation

Long: 0.03 (neutral)

Short: -0.82 (strong negative)

Signal:(52.313) Neutral

Aspira Women's Health Correlation

10 Most Positive Correlations

10 Most Negative Correlations
OZEM	-1
AUERX	-0.887
BGRSX	-0.865
CNWGX	-0.86
FABZX	-0.859
PSTR	-0.859
ESMAX	-0.849
GQGPX	-0.848
IEYAX	-0.846
INDH	-0.844

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aspira Women's Health Correlation - Currency/Commodity

0.24
( neutral )

0.14
( neutral )

0.00
( neutral )

0.03
( neutral )

0.17
( neutral )

-0.28
( neutral )

Aspira Women's Health Financials

Annual	2023
Revenue:	$9.15M
Gross Profit:	$5.26M (57.48 %)
EPS:	$-1.810

FY	2023
Revenue:	$9.15M
Gross Profit:	$5.26M (57.48 %)
EPS:	$-1.810

FY	2022
Revenue:	$8.18M
Gross Profit:	$4.32M (52.77 %)
EPS:	$-41.66

FY	2021
Revenue:	$6.81M
Gross Profit:	$3.06M (44.95 %)
EPS:	$-0.280

Financial Reports:

No articles found.

Aspira Women's Health Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Aspira Women's Health Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0.501 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$0.180	2009-05-21
Last Dividend	$0.260	2016-12-16
Next Dividend	$0	N/A
Payout Date	2016-12-29
Next Payout Date	N/A
# dividends	30	--
Total Paid Out	$8.81	--
Avg. Dividend % Per Year	0.00%	--
Score	1.8	--
Div. Sustainability Score	0.501
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-07-08)

$0 Estimate 0.00 %

Dividend Stability

0.10 Very Bad

Dividend Score

1.80

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
OXLC	Dividend Diamond	2023-12-14	Monthly	14	10.00%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
OXSQ	Dividend Royal	2023-12-14	Monthly	21	9.10%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
HRZN	Dividend Royal	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-1.640	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-2.06	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	12.00	1.500	10.00	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.157	0.800	9.22	7.37	[1 - 3]
quickRatioTTM	0.934	0.800	9.21	7.37	[0.8 - 2.5]
cashRatioTTM	0.645	1.500	7.53	10.00	[0.2 - 2]
debtRatioTTM	0.307	-1.500	4.88	-7.32	[0 - 0.6]
interestCoverageTTM	557.48	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	-1.234	2.00	-0.411	-0.823	[0 - 30]
freeCashFlowPerShareTTM	-1.237	2.00	-0.619	-1.237	[0 - 20]
debtEquityRatioTTM	-1.614	-1.500	-6.46	9.68	[0 - 2.5]
grossProfitMarginTTM	0.588	1.000	3.53	3.53	[0.2 - 0.8]
operatingProfitMarginTTM	-1.922	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-6.65	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	1.255	0.800	4.97	3.97	[0.5 - 2]
Total Score				0.501

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-1.736	1.000	-0.276	0	[1 - 100]
returnOnEquityTTM	12.00	2.50	10.00	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-1.237	2.00	-0.412	-1.237	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-1.234	2.00	-0.411	-0.823	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0858	1.500	-3.91	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-1.626	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-0.778

Aspira Women's Health Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Aspira Women's Health

Aspira Women\'s Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service for decentralized access of protein biomarker and hereditary genetic testing; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, its pipeline products include OVAWatch, EndoCheck, and OVAInherit. The company serves physicians, physician office laboratories, and national and regional laboratories. It has a collaborative research agreement with Baylor Genetics; an agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women\'s Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women\'s Health Inc. in June 2020. Aspira Women\'s Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas.